0001209191-18-056986.txt : 20181102
0001209191-18-056986.hdr.sgml : 20181102
20181102180031
ACCESSION NUMBER: 0001209191-18-056986
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181031
FILED AS OF DATE: 20181102
DATE AS OF CHANGE: 20181102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEHRENS M KATHLEEN
CENTRAL INDEX KEY: 0001211701
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 181158276
MAIL ADDRESS:
STREET 1: 6701 KAISER DRIVE
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-31
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001211701
BEHRENS M KATHLEEN
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2018-10-31
4
M
0
10000
3.96
A
126534
D
Common Stock
2018-10-31
4
S
0
10000
131.71
D
116534
D
Common Stock
21855
I
By Trust
Stock Option (right to buy)
3.96
2018-10-31
4
M
0
10000
0.00
D
2019-03-31
Common Stock
10000
0
D
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.53 to $131.94, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth herein.
The option to purchase shares is fully vested.
/s/ David Tyronne Howton, as attorney-in-fact for M. Kathleen Behrens
2018-11-02